Application of nursing risk management in the quality of nursing management for digestive tract malignant tumors
护理风险管理在消化道恶性肿瘤护理管理质量中的应用

摘要

目的 探讨护理风险管理模式在消化道恶性肿瘤患者护理管理中的应用效果，分析其对护理质量及不良事件发生率的影响。方法 选取本院2024年6月至2025年6月收治的50例消化道恶性肿瘤患者作为研究对象，采用随机数字表法分为对照组与观察组，对照组实施常规肿瘤护理管理，观察组在常规护理基础上引入护理风险管理体系。比较两组护理不良事件发生率、护理满意度、心理状态评分以及康复指标。结果 相较于对照组，观察组的不良事件总发生率呈现出显著的降低趋势；相较于对照组，观察组对护理满意度更高；干预后，观察组SAS、SDS评分低于对照组；观察组首次排气时间、下床活动时间及住院时长均短于对照组（P＜0.05）。结论 将护理风险管理应用于消化道恶性肿瘤患者的护理管理中，可有效降低护理不良事件发生风险，提升护理质量与患者满意度，具有重要的临床推广价值。

Abstract

Objective To explore the application effect of nursing risk management mode in the nursing management of patients with digestive tract malignant tumors, and analyze its impact on nursing quality and incidence of adverse events.
Methods Fifty patients with digestive tract malignant tumors admitted to our hospital from June 2024 to June 2025 were selected as the research subjects. They were randomly divided into a control group and an observation group using a random number table method. The control group received routine tumor nursing management, while the observation group received nursing risk management system in addition to routine nursing. Compare the incidence of adverse nursing events, nursing satisfaction, psychological state scores, and rehabilitation indicators between two groups.
Results Compared with the control group, the total incidence of adverse events in the observation group showed a significant decreasing trend; Compared to the control group, the observation group showed higher satisfaction with nursing care; After intervention, the SAS and SDS scores of the observation group were lower than those of the control group; The observation group had shorter time to first flatus, earlier ambulation, and shorter hospital stay than the control group (P<0.05).
Conclusion   Applying nursing risk management to the nursing management of patients with digestive tract malignant tumors can effectively reduce the risk of nursing adverse events, improve nursing quality and patient satisfaction, and has important clinical promotion value.